US 10870855
Use of MIR101 or MIR128 in the treatment of seizure disorders
granted A61KA61K35/761A61K9/0019
Quick answer
US patent 10870855 (Use of MIR101 or MIR128 in the treatment of seizure disorders) held by OVID THERAPEUTICS INC. expires Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- OVID THERAPEUTICS INC.
- Grant date
- Tue Dec 22 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 17 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K35/761, A61K9/0019, A61K9/0085, A61K9/127